CAT and hepatocellular carcinoma: Several studies suggested that MST silencing, which consequently impedes the catabolism of products directly derived from CAT enzymatic activity, suppresses cancer cell bioenergetics and/or proliferation in hepatoma and lung carcinoma cell lines [125,143].